Oncology Institute (TOI) Equity Ratio (2020 - 2025)
Historic Equity Ratio for Oncology Institute (TOI) over the last 6 years, with Q3 2025 value amounting to 0.08.
- Oncology Institute's Equity Ratio fell 18682.05% to 0.08 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08, marking a year-over-year decrease of 18682.05%. This contributed to the annual value of 0.02 for FY2024, which is 9237.54% down from last year.
- According to the latest figures from Q3 2025, Oncology Institute's Equity Ratio is 0.08, which was down 18682.05% from 0.06 recorded in Q2 2025.
- Oncology Institute's Equity Ratio's 5-year high stood at 0.65 during Q2 2022, with a 5-year trough of 0.08 in Q3 2025.
- In the last 5 years, Oncology Institute's Equity Ratio had a median value of 0.22 in 2021 and averaged 0.27.
- Per our database at Business Quant, Oncology Institute's Equity Ratio skyrocketed by 38721.77% in 2021 and then tumbled by 18682.05% in 2025.
- Oncology Institute's Equity Ratio (Quarter) stood at 0.51 in 2021, then fell by 8.06% to 0.47 in 2022, then crashed by 42.1% to 0.27 in 2023, then crashed by 92.38% to 0.02 in 2024, then tumbled by 461.01% to 0.08 in 2025.
- Its Equity Ratio was 0.08 in Q3 2025, compared to 0.06 in Q2 2025 and 0.03 in Q1 2025.